Dashboard
Manage Tickers

ESPR


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

esperion-secures-additional-commercial-and-medicare-formulary-coverage-for-nexletol-and-nexlizet-new-additions-to-medicare-formularies-at-optumunited-aarp-and-cvssilverscript-coupled-with-humana-provides-access-to-more-than-65-of-medicare-insured-lives-and-more-than-92-of-commercially-insured-lives
Esperion Secures Additional Commercial And...
09/03/2024 12:18:43

– New Additions to Medicare Formularies at Optum/United AARP and CVS/SilverScript Coupled with Humana Provides Access to More T...

needham-maintains-buy-on-esperion-therapeutics-lowers-price-target-to-6
Needham Maintains Buy on Esperion Therapeu...
08/13/2024 10:02:19

Needham analyst Serge Belanger maintains Esperion Therapeutics (NASDAQ:ESPR) with a Buy and lowers the price target from $8 ...

hc-wainwright--co-reiterates-buy-on-esperion-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Espe...
08/12/2024 17:55:11

HC Wainwright & Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $16...

why-ainos-shares-are-trading-higher-by-around-38-here-are-20-stocks-moving-premarket
Why Ainos Shares Are Trading Higher By Aro...
08/12/2024 10:04:36

esperion-reiterates-its-full-year-2024-operating-expense-guidance-of-approximately-225m-245m-including-20m-in-non-cash-expenses-related-to-stock-compensation
Esperion Reiterates Its Full Year 2024 Ope...
08/12/2024 10:02:49

esperion-therapeutics-q2-2024-gaap-eps-033-misses-018-estimate-sales-73834m-may-not-be-comparable-to-49056m-estimate
Esperion Therapeutics Q2 2024 GAAP EPS $(0...
08/12/2024 10:01:26

needham-reiterates-buy-on-esperion-therapeutics-maintains-8-price-target
Needham Reiterates Buy on Esperion Therape...
06/28/2024 17:32:37

Needham analyst Serge Belanger reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $8 price target.

hc-wainwright--co-reiterates-buy-on-esperion-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Espe...
06/28/2024 15:08:29

HC Wainwright & Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $16...

esperion-therapeutics-shares-are-trading-higher-after-the-company-announced-that-it-entered-into-a-royalty-purchase-agreement-with-omers-life-sciences
Esperion Therapeutics shares are trading h...
06/28/2024 11:39:06

esperion-says-it-enters-into-a-royalty-purchase-deal-with-omers-life-sciences-under-which-it-got-3047m-in-exchange-for-100-interest-in-esperions-royalty-entitlement-on-daiichi-sankyo-europes-net-sales-of-bempedoic-acid-products-in-europe
Esperion Says It Enters Into A Royalty Pur...
06/28/2024 11:06:13

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

workday-to-rally-over-52-here-are-10-top-analyst-forecasts-for-thursday
Workday To Rally Over 52%? Here Are 10 Top...
06/20/2024 12:11:28

b-of-a-securities-downgrades-esperion-therapeutics-to-underperform-lowers-price-target-to-25
B of A Securities Downgrades Esperion Ther...
06/20/2024 10:36:03

B of A Securities analyst Jason Zemansky downgrades Esperion Therapeutics (NASDAQ:ESPR) from Neutral to Underperform and low...

why-skye-bioscience-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Skye Bioscience Shares Are Trading Low...
06/10/2024 18:10:40

argan-reports-strong-earnings-joins-geron-planet-labs-pbc-and-other-big-stocks-moving-higher-on-friday
Argan Reports Strong Earnings, Joins Geron...
06/07/2024 14:19:37

hc-wainwright--co-reiterates-buy-on-esperion-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Espe...
05/22/2024 15:59:51

HC Wainwright & Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $16...

european-commission-approve-nilemdo-and-its-combination-with-ezetimibe-nustend-for-hypercholesterolemia-and-reduce-cardiovascular-risk
European Commission Approve NILEMDO And It...
05/22/2024 12:08:01

– NILEMDO (bempedoic acid), a First-In-Class, Oral Treatment and NUSTENDI (bempedoic Acid / Ezetimibe Fixed-Dose Combination) R...

hc-wainwright--co-reiterates-buy-on-esperion-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Espe...
05/21/2024 09:42:24

HC Wainwright & Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $16...

esperion-therapeuticsotsuka-partnered-cholesterol-drug-shows-effective-in-japan-study
Esperion Therapeutics/Otsuka Partnered Cho...
05/20/2024 18:22:42

Esperion Therapeutics and Otsuka Pharmaceutical report Phase 3 trial results for bempedoic acid in Japan, achieving significant...

esperion-otsuka-report-primary-endpoint-was-achieved-in-phase-3-trial-in-japan-for-bempedoic-acid-as-potential-treatment-for-patients-with-hypercholesterolemia
Esperion, Otsuka Report Primary Endpoint W...
05/20/2024 10:02:32

The trial demonstrated statistically significant outcomes on the primary endpoint for bempedoic acid and highlighted its potent...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION